CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-27 | Hansen David K VP Finance & Treasurer | Grant or award · Restricted Stock Units | +200 | 200 | ||
| 2018-12-19 | Zaderej Karen L. CEO | Option exercise · Employee Stock Option (right to purchase) | −30,000 | 0 | ||
| 2018-11-30 | Freitag Gregory Gene General Counsel | Sale | −45,000 | $33.00 | $1.5M | 95,865 |
| 2018-11-19 | Zaderej Karen L. CEO | Option exercise | +30,000 | $2.74 | $82K | 476,209 |
| 2018-11-19 | Zaderej Karen L. CEO | Option exercise | +70,000 | $2.74 | $192K | 452,970 |
| 2018-11-19 | Zaderej Karen L. CEO | Shares withheld for taxes | −6,761 | $28.37 | $192K | 446,209 |
| 2018-11-19 | Zaderej Karen L. CEO | Option exercise · Employee Stock Option (right to purchase) | −70,000 | 0 | ||
| 2018-11-15 | Freitag Gregory Gene General Counsel | Sale | −20,000 | $32.25 | $645K | 140,865 |
| 2018-11-14 | Zaderej Karen L. CEO | Sale | −12,000 | $32.93 | $395K | 382,970 |
| 2018-11-13 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise | +35,000 | $2.74 | $96K | 40,018 |
| 2018-11-13 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Shares withheld for taxes | −2,882 | $33.28 | $96K | 37,136 |
| 2018-11-13 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise | +274 | $0.27 | $74 | 37,410 |
| 2018-11-13 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise · Employee Stock Option (right to purchase) | −35,000 | 0 | ||
| 2018-11-13 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise · Employee Stock Option (right to purchase) | −274 | 0 | ||
| 2018-11-13 | Zaderej Karen L. CEO | Sale | −13,000 | $33.42 | $434K | 394,970 |
| 2018-11-01 | MARTINEZ MARIA D. Chief Human Resources Officer | Grant or award · Employee Stock Option (right to purchase) | +40,000 | 40,000 | ||
| 2018-11-01 | Billet Isabelle Chief Strategy and BD Officer | Grant or award · Employee Stock Option (right to purchase) | +40,000 | 40,000 | ||
| 2018-10-02 | Gold Mark Stephen Director | Gift | −20,000 | 344,761 | ||
| 2018-09-20 | Grooms Jamie Mark Director | Option exercise | +494 | $0.27 | $133 | 6,693 |
| 2018-09-20 | Grooms Jamie Mark Director | Option exercise | +12,000 | $2.75 | $33K | 18,693 |
Page 52 of 61 · 1,220 trades